Czechia Purity greater than 99.8 % confirmed by COA Assay content verified at 4.86 mg Identification confirmed by FTIR and retention time analysis Molecular ion mass identified at 1815 Da Endotoxin level measured at 0.009 EU/mg No detectable heavy metals or microbial contamination AOD-9604 peptide research compound For research use only not for human or veterinary use For laboratory research only
Contact Us: Looking to boost energy and support your wellness
It tackles severe deficiency symptoms
Secure traceability from our lab to your bench
Tri-Amino Acid injections deliver a blend of essential amino acids to support circulation, recovery, and metabolic function
According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption
&srotate=0)
